Efficacy of baricitinib at 12 weeks in this phase II trial was comparable to that of many other psoriatic skin disease medications.
↧
Channel:
NEJM Journal Watch: Dermatology RSS Feed
X
Are you the publisher?
Claim or
contact us
about this channel.
X
0
Channel Details:
- Title: NEJM Journal Watch: Dermatology RSS Feed
- Channel Number: 61520365
- Language: English
- Registered On: March 14, 2016, 7:05 am
- Number of Articles: 27
- Latest Snapshot: March 18, 2016, 10:48 am
- RSS URL: http://www.jwatch.org/dermatology/rss
- Publisher: http://www.jwatch.org/medical-news/rss/448
- Description: Summaries of and commentary on dermatology medical journal articles covering topics such as...
- Catalog: //dermatology1005.rssing.com/catalog.php?indx=61520365
© 2025 //www.rssing.com